Hematologic havoc: haemoglobins link to hypertensive pregnancy outcomes
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20243175Keywords:
Eclampsia, Hemoglobin, Hypertensive disorders, Maternal outcomes, Perinatal outcomes, PregnancyAbstract
Background: Hypertensive disorders of pregnancy (HDP), such as preeclampsia and eclampsia, significantly threaten maternal and perinatal health. This study explores the impact of hemoglobin levels on pregnancy outcomes in women with HDP, aiming to identify potential predictors of adverse outcomes.
Methods: A retrospective analysis was conducted on 233 pregnant women diagnosed with HDP at Sapthagiri Hospital, Bengaluru, from June 2022 to June 2024. Data on patient demographics, hemoglobin levels, and maternal and perinatal outcomes were collected. Statistical analysis was performed using SPSS to examine associations between hemoglobin levels and clinical outcomes.
Results: The study found that low hemoglobin levels (<11 gm%) were associated with a significantly higher incidence of maternal complications (37.8%) compared to normal (15.1%) and high hemoglobin levels (>13 gm%) (35.5%). Eclampsia was more prevalent in women with both low and high hemoglobin levels (17.4% and 17.8%, respectively) compared to those with normal levels. Adverse perinatal outcomes, including increased NICU admissions, stillbirths, and intrauterine fetal demise (IUFD), were also more common in these groups.
Conclusions: The study underscores the importance of maintaining optimal hemoglobin levels during pregnancy to reduce the risk of severe maternal and perinatal complications in women with HDP. Both low and high hemoglobin levels are linked to adverse outcomes, highlighting the need for vigilant monitoring and management throughout pregnancy.
Metrics
References
Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstetr Gynecol. 2008;199(1):55.e1-55.e7.
Hutcheon JA, Lisonkova S, Joseph K. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstetr Gynaecol. 2011;25(4):391-403.
Lu ZM, Goldenberg RL, Cliver S, Cutter G, Blankson M. The relationship between maternal hematocrit and pregnancy outcome. Obstet Gynecol. 1991;77(2):190-4.
Shaikh N, Nahid S, Ummunnisa F, Fatima I, Hilani M, Gul A, et al. Preeclampsia: from etiopathology to organ dysfunction. Preeclampsia. IntechOpen; 2022.
Gudeta TA, Regassa TM. Pregnancy induced hypertension and associated factors among women attending delivery service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci. 2019;29(1):831-40.
Thapa T, Sharma S, Sigdel D, Silwal K, Joshi A. Pregnancy induced hypertension among pregnant women delivering in a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2021;59(244):1209-14.
Usman N, Nadeem S, Sumerakhan, Paul Nankani RM, Gori, Raveesha. Risk factors of hypertensive disorders of pregnancy in a tertiary care hospital. J Popl Ther Clin Pharmacol. 2024;31(4):1071-8.
Thi Huyen Anh N, Manh Thang N, Thanh Huong T. Maternal and perinatal outcomes of hypertensive disorders in pregnancy: Insights from the National Hospital of Obstetrics and Gynecology in Vietnam. PLoS ONE. 2024;19(1):e0297302.
Nankali A, Malek-Khosravi SH, Zangeneh M, Rezaei M, Hemati Z, Kohzadi M. Maternal Complications associated with severe preeclampsia. J Obstet Gynaecol India. 2013;63(2):112-5.
Yücesoy G, Ozkan S, Bodur H, Tan T, Calişkan E, Vural B, et al. Maternal and perinatal Outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven Year experience of a tertiary care center. Arch Gynecol Obstet. 2005;273(1):43-9.
Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hyperten Pregn. 2000;19(2):221-31.
Agida ET, Adeka BI, Jibril KA. Pregnancy outcome in eclamptics at the University of Abuja Teaching Hospital, Gwagwalada, Abuja: a 3 year review. Niger J Clin Pract. 2010;13(4):394-8.
Sah SK, Sunuwar DR, Baral JR, Singh DR, Chaudhary NK, Gurung G. Maternal Hemoglobin and risk of low birth weight: A hospital-based cross-sectional study in Nepal. Heliyon. 202;8(12):e12174.
Wu L, Sun R, Liu Y, Liu Z, Chen H, Shen S, et al. High hemoglobin level is a risk factor for maternal and fetal outcomes of pregnancy in Chinese women: A retrospective cohort Study. BMC Pregnancy Childbirth. 2022;22(1):2.
Das S, Pattanaik T, Sahu M. A study evaluating third trimester haemoglobin level as a Predictor of feto-maternal outcome in pregnancy induced hypertension cases. Int J Reprod Contracept Obstet Gynecol. 2018;7(11):4439.
Dinçgez Çakmak B, Türker ÜA, Öztaş S, Arık M, Üstünyurt E. The effect of first Trimester hemoglobin levels on pregnancy outcomes. Turk J Obstet Gynecol. 2018;15(3):165-70.
Ali SA, Tikmani SS, Saleem S, Patel AB, Hibberd PL, Goudar SS, et al. Hemoglobin concentrations and adverse birth outcomes in South Asian pregnant women: findings from a prospective Maternal and Neonatal Health Registry. Reprod Health. 2020;17(S2).
Gunningham FG. Hypertensive disorders of pregnancy. In; Eastman NJ. Hellman LM, Eds. William obstetrics.19th ed. Norwalk CT: Appleton and Lange; 1993:763-818.
Chappel LL, Bewley S. Pre-eclamptic toxemia: the role of uterine artery Doppler. Br J Obstet Gynaecol. 1998;105(4):379-82.
Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260-5.
Dewey KG, Oaks BM. U-shaped curve for risk associated with maternal hemoglobin, Iron status, or iron supplementation. Ame J Clin Nutrit. 2017;106:1694S-1702S.
Downloads
Published
How to Cite
Issue
Section
